Does NATALIZUMAB Cause Progressive multifocal leukoencephalopathy? 1,668 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,668 reports of Progressive multifocal leukoencephalopathy have been filed in association with NATALIZUMAB (TYRUKO). This represents 2.6% of all adverse event reports for NATALIZUMAB.
1,668
Reports of Progressive multifocal leukoencephalopathy with NATALIZUMAB
2.6%
of all NATALIZUMAB reports
279
Deaths
1,201
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From NATALIZUMAB?
Of the 1,668 reports, 279 (16.7%) resulted in death, 1,201 (72.0%) required hospitalization, and 140 (8.4%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
Yes, Progressive multifocal leukoencephalopathy is listed as a known adverse reaction in the official FDA drug label for NATALIZUMAB.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
BENDAMUSTINE (342)
Which NATALIZUMAB Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK